Dr. Rischard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1501 n Campbell
Tucson, AZ 85724Phone+1 520-626-6380Fax+1 520-296-6224
Summary
- Board certified in pulmonary and critical care. Director, Pulmonary Hypertension Program at the University of Arizona. Research interests in right ventricular function, exercise physiology and precision medicine.
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2000 - 2003
- College of Osteopathic Medicine of the PacificClass of 2000
Certifications & Licensure
- AZ State License 2002 - 2025
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsIncremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension.Roberto Badagliacca, Franz Rischard, Francesco Lo Giudice, Luke Howard, Silvia Papa
The Journal of Heart and Lung Transplantation. 2022-06-01 - 11 citationsResearching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design.Leora I Horwitz, Tanayott Thaweethai, Shari B Brosnahan, Mine S Cicek, Megan L Fitzgerald
Plos One. 2023-01-01 - 262 citationsDevelopment of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.Tanayott Thaweethai, Sarah E Jolley, Elizabeth W Karlson, Emily B Levitan, Bruce Levy
JAMA. 2023-06-13
Press Mentions
- Pulmonary Vascular Disease Phenomics Program PVDOMICS (PVDOMICS)January 13th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: